grant
saveNATSAR PHARMACEUTICALS, INC. — Drug development of RK-33 for breast cancer treatment
September 22, 2025updated 2mo ago
community read0 votes
CA grant. $1,634,811. PI: Dominic A Ventura
view source ↗CA grant. $1,634,811. PI: Dominic A Ventura
view source ↗